Global Rare Disease Genetic Testing Market Projected to Hit USD 5.72 Billion by 2035, at 15.36% CAGR – SNS Insider

U.S. Market Expected to Hit USD 1.80 Billion by 2035; Europe Projected to Reach USD 1.67 Billion as Rare Disease Screening Programs Expand.

U.S. Market Expected to Hit USD 1.80 Billion by 2035; Europe Projected to Reach USD 1.67 Billion as Rare Disease Screening Programs Expand.